The global exosome diagnostic and therapeutic market revenue was around US$ 486 million in 2023 and is estimated to reach US$ 2.3 billion by 2032, growing at a compound annual growth rate (CAGR) of ...

The global TB diagnostic market revenue was around US$ 2.1 billion in 2023 and is estimated to reach US$ 3.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...

Nuclear Medicine Market OverviewThe global nuclear medicine market is poised to experience substantial growth, projected to ...

What you need to know Bacterial meningitis and meningococcal disease are uncommon but life-threatening conditions. Early recognition is important but difficult because of the non-specific ways in ...

Suraksha Diagnostic IPO GMP today was ₹0, which meant shares were trading at their issue price of ₹441 with no premium or discount in the grey market according to investorgain.com.

The issue size of the Suraksha Diagnostic Limited IPO is Rs 846.25 crore which comprises an offer for sale (OFS) of 1.91 ...

Furthermore, the current lack of treatment options may also influence the acceptance of the proposed diagnosis. Summary: Bodily distress syndrome is a diagnostic category with notable validity ...

The flu, COVID-19, and RSV are respiratory infections that may have similar symptoms, including fever, cough, and shortness ...

The following is a summary of “Higher healthcare cost and utilization before and after diagnosis of AATD in the United States ...

The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

The following is a summary of “Age at type 2 diabetes diagnosis and the risk of mortality among US population,” published in the November 2024 issue of Endocrinology by Zhang et al. Type 2 diabetes ...